Cargando…

Selective steroid oxyfunctionalisation by CYP154C5, a bacterial cytochrome P450

BACKGROUND: Cytochrome P450 monooxygenases – able to regio- and stereoselectively hydroxylate non-activated carbon atoms – are important enzymes for the synthesis of valuable intermediates in the production of steroid hormones in the pharmaceutical industry. However, up to now only a few bacterial e...

Descripción completa

Detalles Bibliográficos
Autores principales: Bracco, Paula, Janssen, Dick B, Schallmey, Anett
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015549/
https://www.ncbi.nlm.nih.gov/pubmed/24134652
http://dx.doi.org/10.1186/1475-2859-12-95
_version_ 1782315354560659456
author Bracco, Paula
Janssen, Dick B
Schallmey, Anett
author_facet Bracco, Paula
Janssen, Dick B
Schallmey, Anett
author_sort Bracco, Paula
collection PubMed
description BACKGROUND: Cytochrome P450 monooxygenases – able to regio- and stereoselectively hydroxylate non-activated carbon atoms – are important enzymes for the synthesis of valuable intermediates in the production of steroid hormones in the pharmaceutical industry. However, up to now only a few bacterial enzymes able to hydroxylate steroids have been reported. CYP154C5 from Nocardia farcinica IFM 10152, a bacterial P450 monooxygenase, was previously shown to convert testosterone to 16α-hydroxytestosterone. Since the hydroxylation at 16α-position is of special interest for the pharmaceutical industry, we have studied this enzyme in more detail to investigate its activity and selectivity in bioconversions of further steroids. RESULTS: CYP154C5 was coexpressed in Escherichia coli together with putidaredoxin and putidaredoxin reductase from Pseudomonas putida as redox partners for electron transfer and applied in bioconversions of various pregnanes and androstanes [pregnenolone (1), dehydroepiandrosterone (2), progesterone (3), androstenedione (4), testosterone (5) and nandrolone (6)]. Structure elucidation of the formed products revealed an exclusive regio- and stereoselectivity of CYP154C5, always yielding the corresponding 16α-hydroxylated steroids. Application of whole cells expressing the three components, P450, Pdx and PdR, in steroid biotransformations resulted in significantly higher conversions and total turnover numbers (TTN) compared to reactions using cell-free extracts. Additionally, considerably higher substrate loads (up to 15 mM) were tolerated by the whole-cell system. Furthermore, turnover numbers (TON) were determined for the six different steroids using whole cells. Thus, testosterone was found to be the worst substrate with a TON of only 0.8 μmol substrate consumed min(-1) μmol(-1) CYP154C5, while progesterone and pregnenolone were converted the fastest resulting in TON of 3.3 μmol substrate consumed min(-1) μmol(-1) CYP154C5. CONCLUSION: CYP154C5 from N. farcinica constitutes a promising catalyst due to its high regio- and stereoselectivity in the hydroxylation of different steroids as well as its efficient expression in E. coli at high yields. Using this enzyme, 16α-hydroxylated steroids, which are important precursors for the synthesis of high value steroidal drugs in the pharmaceutical industry, can be selectively produced on preparative scale with TTN (μmol substrate consumed μmol(-1) CYP154C5) exceeding 2000.
format Online
Article
Text
id pubmed-4015549
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40155492014-05-10 Selective steroid oxyfunctionalisation by CYP154C5, a bacterial cytochrome P450 Bracco, Paula Janssen, Dick B Schallmey, Anett Microb Cell Fact Research BACKGROUND: Cytochrome P450 monooxygenases – able to regio- and stereoselectively hydroxylate non-activated carbon atoms – are important enzymes for the synthesis of valuable intermediates in the production of steroid hormones in the pharmaceutical industry. However, up to now only a few bacterial enzymes able to hydroxylate steroids have been reported. CYP154C5 from Nocardia farcinica IFM 10152, a bacterial P450 monooxygenase, was previously shown to convert testosterone to 16α-hydroxytestosterone. Since the hydroxylation at 16α-position is of special interest for the pharmaceutical industry, we have studied this enzyme in more detail to investigate its activity and selectivity in bioconversions of further steroids. RESULTS: CYP154C5 was coexpressed in Escherichia coli together with putidaredoxin and putidaredoxin reductase from Pseudomonas putida as redox partners for electron transfer and applied in bioconversions of various pregnanes and androstanes [pregnenolone (1), dehydroepiandrosterone (2), progesterone (3), androstenedione (4), testosterone (5) and nandrolone (6)]. Structure elucidation of the formed products revealed an exclusive regio- and stereoselectivity of CYP154C5, always yielding the corresponding 16α-hydroxylated steroids. Application of whole cells expressing the three components, P450, Pdx and PdR, in steroid biotransformations resulted in significantly higher conversions and total turnover numbers (TTN) compared to reactions using cell-free extracts. Additionally, considerably higher substrate loads (up to 15 mM) were tolerated by the whole-cell system. Furthermore, turnover numbers (TON) were determined for the six different steroids using whole cells. Thus, testosterone was found to be the worst substrate with a TON of only 0.8 μmol substrate consumed min(-1) μmol(-1) CYP154C5, while progesterone and pregnenolone were converted the fastest resulting in TON of 3.3 μmol substrate consumed min(-1) μmol(-1) CYP154C5. CONCLUSION: CYP154C5 from N. farcinica constitutes a promising catalyst due to its high regio- and stereoselectivity in the hydroxylation of different steroids as well as its efficient expression in E. coli at high yields. Using this enzyme, 16α-hydroxylated steroids, which are important precursors for the synthesis of high value steroidal drugs in the pharmaceutical industry, can be selectively produced on preparative scale with TTN (μmol substrate consumed μmol(-1) CYP154C5) exceeding 2000. BioMed Central 2013-10-17 /pmc/articles/PMC4015549/ /pubmed/24134652 http://dx.doi.org/10.1186/1475-2859-12-95 Text en Copyright © 2013 Bracco et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Bracco, Paula
Janssen, Dick B
Schallmey, Anett
Selective steroid oxyfunctionalisation by CYP154C5, a bacterial cytochrome P450
title Selective steroid oxyfunctionalisation by CYP154C5, a bacterial cytochrome P450
title_full Selective steroid oxyfunctionalisation by CYP154C5, a bacterial cytochrome P450
title_fullStr Selective steroid oxyfunctionalisation by CYP154C5, a bacterial cytochrome P450
title_full_unstemmed Selective steroid oxyfunctionalisation by CYP154C5, a bacterial cytochrome P450
title_short Selective steroid oxyfunctionalisation by CYP154C5, a bacterial cytochrome P450
title_sort selective steroid oxyfunctionalisation by cyp154c5, a bacterial cytochrome p450
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015549/
https://www.ncbi.nlm.nih.gov/pubmed/24134652
http://dx.doi.org/10.1186/1475-2859-12-95
work_keys_str_mv AT braccopaula selectivesteroidoxyfunctionalisationbycyp154c5abacterialcytochromep450
AT janssendickb selectivesteroidoxyfunctionalisationbycyp154c5abacterialcytochromep450
AT schallmeyanett selectivesteroidoxyfunctionalisationbycyp154c5abacterialcytochromep450